Unclear Diagnoses in Patients with Metastatic Disease

Ralph V. Boccia, MD, FACP

Video Categories: PMO Interview with the Innovator Series: Volume 9

Dr. Boccia addresses the problem of unclear diagnoses affecting approximately 15% of newly diagnosed patients with metastatic disease each year and the importance of an accurate diagnosis of tumor type in selecting the proper site-specific therapies.
March 24, 2015

The Global Challenge of Personalized Medicines

Dr. Stainthorpe explains that when it comes to bringing personalized medicines to fruition, the challenge is the same worldwide. It is an effort that requires better understanding of disease pathways and markers as well as improved diagnostics.

January 20, 2016

Targeting Resistant Cells

Dr Wainberg and Dr Gerson talk about going after this cell population and some of the findings of myeloid leukemia research.